Aier(SZ:300015) Sou Hu Cai Jing·2025-08-26 08:45Core Viewpoint - Aier Eye Hospital Group reported a revenue of 60.26 billion RMB for Q1 2025, reflecting a year-on-year growth of 15.97% and a net profit of 10.50 billion RMB, up 16.71% from the previous year [1] Financial Performance - Total revenue for Q1 2025: 60.26 billion RMB, a 15.97% increase year-on-year [1] - Net profit: 10.50 billion RMB, a 16.71% increase year-on-year [1] - Non-recurring net profit: 10.60 billion RMB, a 25.78% increase year-on-year [1] - Current ratio: 1.615 [1] - Quick ratio: 1.481 [1] - Debt-to-asset ratio: 33.30% [1] Stock Performance - Stock price as of August 26, 2025: 13.83 RMB, up 0.58% [1] - Turnover rate: 1.64% [1] - Trading volume: 1.3036 million hands [1] - Trading amount: 1.794 billion RMB [1] - Net inflow of main funds: 85.99 million RMB, accounting for 4.79% of trading volume [1] - Large single net inflow: 6.32 million RMB, accounting for 0.35% of trading volume [1] - Large order net inflow: 79.67 million RMB, accounting for 4.44% of trading volume [1] - Medium order net outflow: 2.76 million RMB, accounting for 0.15% of trading volume [1] - Small order net outflow: 83.23 million RMB, accounting for 4.64% of trading volume [1] Company Overview - Aier Eye Hospital Group was established in 2003 and is located in Changsha [2] - The company primarily engages in health-related services [2] - Registered capital: 932.54 million RMB; paid-in capital: 923.68 million RMB [1][2] - Legal representative: Chen Bang [1] Investment and Intellectual Property - Aier Eye Hospital has invested in 380 companies [2] - Participated in 29 bidding projects [2] - Holds 102 trademark registrations and 69 patents [2] - Possesses 15 administrative licenses [2]